Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for hospitalized patients with COVID-19 pneumonia
IRCT20200608047686N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in coronavirus disease 2019 (COVID-19) comparing Metronidazole plus standard of care with Standard of care control (2 arms). Primary endpoints: Oxygen saturation and Length of hospital stay. Started May 2020; status: completed.
02
Drugs
metronidazole
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200608047686N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200608047686N1.